IPO Announced
SpyGlass Pharma IPO
US$150m raised
Lodged 5 Feb 2026 · NASDAQ: SGP · US$16.00 per share
Advisers
SpyGlass Pharma
Issuer
Not disclosed
Lead managers
- Bookrunner
- Legal adviser
- Issuer
- SpyGlass Pharma
- Issuer based in
- United States
- Sector
- Ophthalmology
- Tags
- Ophthalmology, Pharma
Similar deals
- Quince Therapeutics placement May 2026 · US$115m · Biotech
- Agomab Therapeutics NV IPO Feb 2026 · US$200m · Biotech
- Seaport Therapeutics IPO Apr 2026 · US$255m · Biotech
- Veradermics IPO Feb 2026 · US$256m · Dermatology
- Mentari Therapeutics placement May 2026 · US$290m · Biotech
Sources
- 6 Feb 2026 Final IPO prospectus (424B4), SpyGlass Pharma, Inc. sec.gov
- 6 Feb 2026 Latham Advises on SpyGlass Pharma Initial Public Offering lw.com



